Abstract:Diabetes has been identified as a risk factor for AD as well as cognitive decline. The association between diabetes and AD is unclear, with both direct effects on beta amyloid and indirect effects through vascular disease possible. We report the findings of a cross-sectional study in Shanghai, China, comparing cases of dementia with cases of amnestic MCI (aMCI) and normal controls. An age- and sex-matched sample of 34 dementia patients, 30 aMCI patients and 32 normal controls (mean age =74.0, 49% female) was given MRI scans, a comprehensive neuropsychological battery, neurological exams, and an extensive risk factor evaluation. Logistic regression analyses were used to compare aMCI patients with normals as well as dementia patients with aMCI patients. Independent variables included age, sex, educational level, modified Hachinski ischemic score (a summary measure of vascular risk), WMHI volume, and fasting blood glucose. Additional linear regressions were run to assess the association of blood glucose with measures of memory, executive function, and psychomotor speed. Controlling for age, sex, education, Hachinski score and WMHI volume; higher blood glucose was associated with dementia vs. aMCI status (OR= 2.88; 95%CI: 1.17-7.10). Removal of 3 cases meeting NINDS-AIREN criteria for probable vascular dementia had little effect on the association (OR=3.16, 95%CI: 1.29-7.76). Similar analyses comparing aMCI vs. normal control status did not show a significant association (OR= 0.59, 95%CI: 0.28-1.24). Higher glucose was associated with Mattis Inititation Score (p=.02), Mattis Total Score (p=.03), Trails B time (p=.03) and Bell cancellation test score (p=.04), but not with other neuropsychological measures including scores on the Stroop test, WAIS-Similarities, Boston Naming Test, Clock Drawing Test, and several measures of verbal and visual memory. Higher blood glucose was associated with increased risk of dementia in comparison with aMCI, but was not associated with risk of aMCI vs. normal control status. Examination of neuropsychological data suggested that the increased risk may be related to poorer performance on tests of perceptual speed as previously reported (Arvanitakis et al., 2004). The results suggest that treatment of diabetes in individuals in early stages of AD may be useful in slowing progression.

Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance

Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China

The Relationship Between Plasma DPP4 Activity to BDNF Ratio and Mild Cognitive Impairment in Elderly Population with Normal Glucose Tolerance

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

Plasma Superoxide Dismutase Activity in Relation to Disability in Activities of Daily Living and Objective Physical Functioning among Chinese Older Adults

Association Between Plasma Dipeptidyl Peptidase-4 Activity to Brain-Derived Neurotrophic Factor Ratio and Depressive Symptoms in Middle-Aged and Older Adults with Normal Glucose Tolerance: A Cross-Sectional Study

Increased Plasma DPP4 Activities Predict New-Onset Hyperglycemia in Chinese over a Four-Year Period: Possible Associations with Inflammation

Increased Plasma DPP4 Activities Predict New-Onset Atherosclerosis in Association with Its Proinflammatory Effects in Chinese over a Four Year Period: A Prospective Study.

The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease

Association between plasma dipeptidyl peptidase-4 levels and cognitive function in perinatal pregnant women with gestational diabetes mellitus

Nonenzymatic function of DPP4 in diabetes‐associated mitochondrial dysfunction and cognitive impairment

Increased Plasma DPP4 Activity is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study.

The Relationships Between Plasma Advanced Glycation End Products Level and Cognitive Function in Middle-Aged and Elderly Chinese Subjects.

Association of β-cell function and cognitive impairment in patients with abnormal glucose metabolism

Plasma sDPP4 (Soluble Dipeptidyl Peptidase-4) and Cognitive Impairment After Noncardioembolic Acute Ischemic Stroke

Relationship between triglyceride-glucose index and cognitive function among community-dwelling older adults: a population-based cohort study

Increased Plasma DPP4 Activity is Predictive of Prediabetes and Type 2 Diabetes Onset in Chinese over a Four-Year Period: Result from the China National Diabetes and Metabolic Disorders Study.

Association of glycogen synthase kinase-3β with cognitive impairment in type 2 diabetes patients: a six-year follow-up study

Association of Triglyceride-Glucose Index With Cognitive Function and Brain Atrophy: A Population-Based Study

Correlation between serum dipeptidyl peptidase 4 activity and abnormal lipid metabolism

P3‐119: Higher blood glucose is associated with dementia among Chinese elderly independent of vascular risk factors and white matter hyperintensity volume: findings from SCOBHI